- Report
- May 2024
- 140 Pages
Global
From €6350EUR$6,499USD£5,301GBP
- Report
- May 2024
- 134 Pages
Global
From €6350EUR$6,499USD£5,301GBP
- Report
- July 2024
- 70 Pages
Global
From €4641EUR$4,750USD£3,874GBP
- Report
- February 2024
- 126 Pages
Global
From €4641EUR$4,750USD£3,874GBP
- Report
- February 2024
- 100 Pages
Global
From €4641EUR$4,750USD£3,874GBP
- Report
- February 2024
- 106 Pages
Global
From €4641EUR$4,750USD£3,874GBP
- Report
- February 2024
- 150 Pages
Global
From €4641EUR$4,750USD£3,874GBP
- Clinical Trials
- November 2024
- 450 Pages
Global
From €4885EUR$5,000USD£4,078GBP
- Drug Pipelines
- November 2024
- 240 Pages
Global
From €2931EUR$3,000USD£2,447GBP
- Report
- July 2024
- 150 Pages
Global
From €2565EUR$2,625USD£2,141GBP
€3664EUR$3,750USD£3,059GBP
- Report
- July 2024
- 150 Pages
Global
From €2565EUR$2,625USD£2,141GBP
€3664EUR$3,750USD£3,059GBP
- Report
- June 2024
- 200 Pages
Global
From €5437EUR$5,565USD£4,539GBP
€7768EUR$7,950USD£6,485GBP
- Report
- June 2024
- 200 Pages
Global
From €5437EUR$5,565USD£4,539GBP
€7768EUR$7,950USD£6,485GBP
- Report
- June 2024
- 200 Pages
Global
From €5437EUR$5,565USD£4,539GBP
€7768EUR$7,950USD£6,485GBP
- Report
- June 2024
- 200 Pages
Global
From €5437EUR$5,565USD£4,539GBP
€7768EUR$7,950USD£6,485GBP
- Report
- June 2024
- 200 Pages
Global
From €5437EUR$5,565USD£4,539GBP
€7768EUR$7,950USD£6,485GBP
- Drug Pipelines
- June 2024
- 80 Pages
Global
From €1368EUR$1,400USD£1,142GBP
€1954EUR$2,000USD£1,631GBP
- Clinical Trials
- April 2024
- 40 Pages
Global
From €855EUR$875USD£714GBP
€1221EUR$1,250USD£1,020GBP
- Drug Pipelines
- April 2024
- 220 Pages
Global
From €2052EUR$2,100USD£1,713GBP
€2931EUR$3,000USD£2,447GBP
- Report
- April 2024
- 30 Pages
Global
From €2223EUR$2,275USD£1,856GBP
€3175EUR$3,250USD£2,651GBP
The Diabetes Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat diabetes. Diabetes is a chronic condition that affects millions of people worldwide, and the drugs used to treat it can help to manage the symptoms and reduce the risk of complications. Commonly prescribed diabetes drugs include insulin, sulfonylureas, meglitinides, thiazolidinediones, and DPP-4 inhibitors. These drugs are used to help regulate blood sugar levels, reduce insulin resistance, and improve the body's ability to use insulin.
Some of the major companies in the Diabetes Drugs market include Novo Nordisk, Sanofi, Eli Lilly, Merck, and AstraZeneca. These companies are involved in the research, development, and marketing of diabetes drugs, and they are constantly striving to develop new and improved treatments for the condition. Show Less Read more